Quanterix Corporation Common Stock (QTRX)

FairStock Score: 49/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for businesses that earn consistent profits and can be bought at a discount to intrinsic value. Quanterix does not yet fit that mold. It sells protein detection instruments, including HD-X, SR-X, and SP-X, but the numbers show a company still searching for scale. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $32.9M and net income was -$48.9M, or diluted EPS -$1.04. A year earlier, in fiscal Q2 2025, the quarter ended 2025-06-30, revenue was $24.5M and net income was -$30.0M. Revenue is moving up, but the loss is widening. For FY2025, period ended 2025-12-31, revenue was $138.9M and net income was -$107.2M, compared with FY2024 revenue of $137.4M and net income of -$38.5M. That is not the compounding I want. Financial health is poor on the operating side. FairStock's calculated ROE is -46.48% and ROCE is -16.67%; trailing free cash flow is -$81.7M, a FairStock FCF yield of -54.8%. The Piotroski score is 2/9 and Altman Z-score is -1.41, both warning signs. The balance sheet has low debt, with D/E of 0.14, which helps. At the $3.15 close on 2026-10-13, FairStock calculates P/B of 0.63 and P/E of -1.20. Price below book can be a starting point, but only if book value is real and earning power is near. FairStock's Lynch category is none because it lost money in each of the last four years. I see a speculative turnaround, not a Graham-style bargain. Growth must eventually become cash.

In plain English: Quanterix makes laboratory instruments and tests used to measure proteins in life-science research. Revenue is growing, but the company keeps losing money and burning cash, so the business looks weak on profitability. At $3.15 at the 2026-10-13 close, the price looks low compared with its stated net assets, but it still looks speculative because there are no profits.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer